| INTRODUC TI ON
The incidences of stroke and post-stroke mortality have declined heavily in high-income countries in the last 50 years, mainly because of changes in cardiovascular risk factors and improvements in acute stroke treatment.
1 Despite progress and declining trends, recurrent stroke is still frequent. 2, 3 Studies demonstrate varying recurrence rates, ranging from 7%-20% at 1 year to 16%-35% at 5 years. 4, 5 Recurrent ischemic stroke (IS) has been associated with increased mortality and functional dependence, 6, 7 but this remains insufficiently explored. The primary goal of secondary prevention strategies after IS or transient ischemic attack (TIA) is to reduce the risk of recurrent stroke, and information on stroke recurrence and survival is useful to assess the effect of secondary prevention and risk factors for recurrence and death.
In this study, we aimed to investigate the cumulative incidence of recurrent IS or TIA in a Norwegian hospital-based stroke population, as well as investigate factors associated with recurrence. We also wanted to assess the all-cause mortality after IS or TIA and the influence of recurrence on mortality.
| MATERIAL S AND ME THODS
In this hospital-based prospective cohort, all patients older than 18 years admitted with IS or TIA to the Stroke Unit at the Department of Neurology, Haukeland University Hospital, be- 
| S TATI S TI C S

| RE SULTS
During the inclusion period, 1988 patients were diagnosed with IS or TIA, of whom 116 died during the index admission or were dis- were not assigned any secondary prevention, mainly because of con- During a mean follow-up of 5.6 years (median 5.5 years, max. Table 3 . Recurrent IS or TIA was the strongest risk factor for death, with a 2.5-fold increase in the all-cause mortality adjusted for known factors independently increasing the risk of death such as smoking, diabetes, coronary artery disease, older age, and stroke severity at discharge. When we excluded the 25 patients with TIA as the first recurrent event from the mortality analysis, a 2.6-fold increase in the risk of death in patients with recurrent IS was found. Patients treated with statins for high cholesterol had a lower risk of death.
| DISCUSS ION/CON CLUS ION
In this prospective cohort study, the cumulative incidence of clinical recurrent IS or TIA was 5.4% at 1 year and 11.3% at 5 years. This is F I G U R E 1 Cumulative incidence of first recurrence of ischemic stroke or TIA considerably lower compared with a meta-analysis from 2011, which estimated a pooled cumulative risk of 11.1% at 1 year and 26.4% at 5 years. 4 One explanation for this difference could be the declining incidences of stroke recurrence, which have been observed in studies on temporal trends of recurrence. 2, 3 Furthermore, optimal use of secondary prevention strategies has shown a significant reduction in the absolute risk of recurrence. 13 Almost all patients in our study were prescribed antiplatelet or anticoagulant treatment, and the use of statins and antihypertensive treatment was high compared to other studies. 14 Finally, differences in populations, methods, and use of statistical analyses in studies on recurrence make comparison between them difficult. The Kaplan-Meier survival analysis may overestimate the cumulative incidence of recurrence since death is not treated as a competing risk. 15 Recent studies adjusting for competing risk of death have reported 1-and 5-year incidences of recurrence of 3.6%-7.7% and 10.1%-16.8%. [16] [17] [18] [19] Our results are thus supporting newer data from several other populations.
Among the factors associated with recurrence in our study, previous hypertension at index stroke was the strongest one.
Hypertension is usually considered the single most important risk factor for first stroke, but its role in the risk of recurrence is uncertain. Some studies have reported this association, 7, 20 while other studies have found diabetes, coronary heart disease, and atrial fibrillation as the strongest risk factors. 21, 22 Neither of these were independently associated with recurrence in our study and did not differ between patients with or without recurrence ( Table 1) . No single factor has been consistently associated with recurrent IS or TIA.
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Case mix, changes in risk factor profiles, and risk factor control may affect the significance of independent factors over time and influence the results of individual studies.
In our cohort, we studied a general hospital-based stroke population for recurrence and included patients with a history of IS or TIA 
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Recurrent ischemic stroke or TIA was a strong independent factor doubling the mortality risk in our cohort. Despite the overall high incidence of recurrent stroke, few studies have investigated the impact of recurrence on all-cause mortality. Studies have reported unadjusted estimates ranging from a 2-fold increase in mortality to a 17-fold increase. 7, 24 However, two other studies using similar statistical approaches as in our study reported adjusted relative mortality risks of 2.7 and 3.0 after recurrence, 6, 25 which are more similar to our findings. The mechanisms behind how recurrence affects mortality are not well studied. Stroke severity is considered the most significant factor influencing short-and long-term outcome after stroke, 26 and when recurrent stroke adds to existing neurological deficit, patients may be more prone to complications and a worse outcome. One study found that a contralateral recurrent stroke led to more severe functional disability than patients with ipsilateral recurrence, which reduces the brain's ability to compensate.
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Our study has limitations. First, we may have underestimated the true incidence of recurrence, as recurrent events were identified by review of medical records, and thus patients had to be admitted to a hospital within our region to be included as a recurrent event.
Furthermore, we have no data on drug compliance and scarce data on cause of death, which limits the interpretation of factors affecting mortality. Finally, the findings from our Caucasian population with mostly mild IS or TIA and high rates of secondary prevention may not be transferable to other demographics.
The main strength of this study is that we have obtained highquality 1-and 5-year recurrence and mortality data in a hospitalbased stroke population. A predefined investigation protocol and the use of electronic medical records for identification of recurrent IS or TIA provide precise and accurate clinical data on both index event and on the recurrent episode as compared to studies using administrative data. All ischemic stroke cases were confirmed with imaging studies. On this background, we conclude that the risk of recurrent IS or TIA is modest in our population and that recurrent stroke has a high negative impact on all-cause mortality.
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